0001062993-23-016523.txt : 20230815
0001062993-23-016523.hdr.sgml : 20230815
20230815161537
ACCESSION NUMBER: 0001062993-23-016523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230814
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Banks Robert R. Jr.
CENTRAL INDEX KEY: 0001977237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32288
FILM NUMBER: 231175033
MAIL ADDRESS:
STREET 1: C/O 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEPHROS INC
CENTRAL INDEX KEY: 0001196298
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 133971809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
BUSINESS PHONE: 201.343.5202
MAIL ADDRESS:
STREET 1: 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-08-14
0001196298
NEPHROS INC
NEPH
0001977237
Banks Robert R. Jr.
380 LACKAWANNA PLACE
SOUTH ORANGE
NJ
07079
1
1
0
0
President and CEO
0
Common Stock
2023-08-14
4
P
0
99
1.50
A
99
D
Common Stock
2023-08-15
4
P
0
1901
1.6869
A
2000
D
Stock Option (right to buy)
1.44
2033-05-05
Common Stock
357165
357165
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.73, inclusive. The reporting person undertakes to provide Nephros Inc., any security holder of Nephros Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the set range set forth in this footnote.
Options to purchase 89,291 shares vest on 5/5/24 and options to purchase 267,874 shares vest quarterly in 12 equal amounts commencing on 8/5/24.
/s/ Edward Peilen as attorney-in-fact for Robert R. Banks, Jr. pursuant to power of attorney filed herewith.
2023-08-15
EX-24
2
exhibit24.txt
POA
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints Christopher
Melsha and Edward Peilen, or either of them acting alone, the undersigned's
true and lawful attorney-in-fact and agent with full power of substitution
and resubstitution, for the undersigned and in the undersigned's name,
place and stead, in any and all capacities, to sign any or all Forms 3,
Forms 4 and Forms 5 relating to beneficial ownership of securities of
Nephros Inc. (the "Issuer"), to file the same, with all exhibits thereto
and other documents in connection therewith, with the Securities and
Exchange Commission and to deliver a copy of the same to the Issuer,
granting unto said attorney-in-fact and agent full power and authority
to do and perform each and every act and thing requisite and necessary
to be done in and about the premises, as fully to all intents and purposes
as the undersigned might or could do in person, hereby ratifying and
confirming all said attorneys-in-fact and agent, or his substitute or
substitutes, may lawfully do or cause to be done by virtue thereof. The
undersigned acknowledges that the foregoing attorney-in-fact, in serving
in such capacity at the request of the undersigned, is not assuming any
of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934.
This Power of Attorney shall remain in effect until such time as
the undersigned is no longer subject to the provisions of Section 16 of
the Securities Exchange Act of 1934 with respect to securities of the
Issuer.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 15th day of May, 2023.
/s/ Robert R. Banks
Robert R. Banks